Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 07:54 am Sale |
2024-12-31 | 13G | Dianthus Therapeutics, Inc. DNTH |
BCLS Fund III Investments, LP | 2,689,707 8.800% |
-302,321 (-10.10%) |
Filing History |
| 2024-10-18 6:10 pm Purchase |
2024-10-15 | 13G | Upstream Bio, Inc. UPB |
BCLS Fund III Investments, LP | 2,295,322 4.300% |
2,295,322 (New Position) |
Filing History |
| 2024-07-29 4:45 pm Purchase |
2024-07-18 | 13G | Cidara Therapeutics, Inc. CDTX |
BCLS Fund III Investments, LP | 703,080 9.990% |
703,080 (New Position) |
Filing History |
| 2024-02-02 4:32 pm Purchase |
2024-01-24 | 13G | Dianthus Therapeutics, Inc. DNTH |
BCLS Fund III Investments, LP | 2,992,028 9.990% |
2,992,028 (New Position) |
Filing History |